A high risk of malignant ovarian tumors is observed in women over the age of 49 with a burdened hereditary history (mutations of the BRCA1 and BRCA2 genes, Lynch syndrome, etc.)and after ovarian hyperstimulation, when using hormone replacement therapy, endometriosis, or obesity. This evidence concerns the gene BRCA1 and endometriosis.